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Abstract: 
Antibiotics are the metabolic by products of complex biosynthetic pathways in the microorganisms. They are often 
touted as one of the most important discoveries of the modern medicine. It contributes to save millions of lives and 
to control the majority of bacterial infectious diseases. Intensive research on antibiotics has been carried out 
globally for approximately thirty five to forty years whereas the search for new antibiotics still continues in a rather 
over looked hunting grounds. Recent studies dealt with the search for new antibiotics and their interest stemmed in 
the soil microbials due to its large biodiversity in search for new useful compounds. There are also reports 
presented by different researchers on the secondary metabolites potential of different Bacterial, Fungal and 
Antinomycetes species. This article compiles the historical background, factors, needs, source and future prospects 
of secondary metabolites and the role and bioactivity of microorganisms’ in habitat in soil for the development of 
new antibiotics as a life saving agents for everyone. To determine microbial diversity within the soil is crucial in the 
past but with the new methods it is now possible to detect both culturable and un-culturable microbial species. It is 
a brief overview of the antibiotic development through years and its emergence. Thus in this review contribution of 
soil microbials for the development of novel antibiotics and designing more effective preventive measures in the 
future have been discussed. 
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INTRODUCTION: 
Secondary metabolites are the important candidate 
for the development of drugs or other technological 
development. Secondary metabolites may be 
produced from natural sources i.e., from fungi, 
bacteria, plants and many of the marine-organisms 
(tunicates, corals, snails, etc). Secondary metabolites 
were produced from the organisms that were able to 
inhibit the growth of other organism’s competing for 
the same ecological niche. Broadly antibiotics can be 
defined as a chemically heterogeneous group 
consisting of organic molecules having microbial 
origin. At low concentration, antibiotics were 
deleterious to metabolic activities and it inhibits the 
growth of many other microorganisms [1]. The term 
“antimicrobials” includes all the agents that act 
against all other types of microorganisms that 
includes bacteria (anti-bacterial), fungi (anti-fungal), 
viruses (anti-viral), protozoa (anti-protozoal) and 
antitumor. Nowadays microorganisms present in the 
soil became an important source for the intensive 
search of important molecules used in industries [2]. 
Many of the microorganisms were diversely 
distributed in the nature and were still unknown, yet 
many more important molecules or useful products 
were to be identified from soil microbial having the 
potential to produce new antibiotics. Today both 
industrial and academic interest in soil 
microorganisms is on rise in search of novel 
commercially important products and unique 
biologically active metabolites from them. The 
diversity of the microorganisms present in soil was of 
great significance due to its importance in the early 
discoveries of useful antibiotics [3]. Microorganisms 
in the soil such as bacteria, protozoa, algae and 
moulds were competing under limited nutrients have 
to devise strategies for their survival. Although the 
first commercially produced antibiotic penicillin, was 
discovered by the chance where most of the today’s 
produced antibiotics were discovered by systematic 
searching. Thus attention is always turned to the soil 
whenever the new antibiotic producers are being 
sought [4]. Filamentous microorganisms such as 
Actinomycetes & Fungi were main source of 
secondary metabolites that were able to produce 
antibiotics. The filamentous microorganisms freshly 
isolated from soil are the important source of 
secondary metabolites. The nature has immense 
potential to provide structurally diverse broad 
spectrum secondary metabolites [5].   
 
Definition of Antibiotics 
Antibiotics are low molecular weight and biological 
active compounds [6]. The word antibiotic was 
proposed by Selman Waksman in 1945, he defined 
antibiotic as a microbial origin chemical substance. 
Further in 1981 Webster’s Third International 
Dictionary termed antibiotic as a natural substance 
produced by a microorganism that inhibit or kill other 
microorganisms. Furthermore, Brock’s deﬁne 
antibiotic as a chemical agent released by a 
microorganism that is harmful for another organisms 
[7]. Gottlieb and Shaw (1967) defined antibiotics as 
an organic substance that was produced from many 
microorganisms that at low concentration was 
harmful to the growth and metabolic activities of 
other microorganisms [8]. Lancini and Parenti (1982) 
defined antibiotics as low molecular weight special 
inhibitory products that exclude lactic acid, enzymes, 
ethanol and other substances that prevents the growth 
of other microorganisms [9]. Though in the middle of 
the last century, in clinical practices antibiotics was 
introduced for the management of microbial 
infections. In ancient Greece, China, Egypt and other 
places of the world the use of microorganisms was 
well documented. The modern era of the antibiotics 
was started when Alexander Fleming in 1928 
discover penicillin from fungus, Penicillium notatum 
[10]. 
 
Discovery and Origin of Antibiotics  
Antibiotics have been used for more than fifty years 
to cure infectious diseases [7]. Prior to the 1940s, 
infectious diseases were either treated with 
antiseptics, silver compounds, surgical drainage, 
tincture and with arsenicals of the time. Over the 
latter half of the 20th century the rapid succession of 
antibiotics was miraculous which provide clinicians 
to treat the bacterial infections [11]. Endocarditis was 
almost fatal and diagnosis of meningitis or 
pneumonia was a death sentence. During the half of 
the 19th century, Robert Koch was working to 
identify microorganisms that cause diseases such as 
typhoid, cholera and tuberculosis. Scientist of time 
studied different methods such as vaccination for 
fighting infectious diseases. Besides their fatal effect 
scientists were also carrying out research to find out 
effective antibiotics and antibacterial agents from 
these microorganisms. By the 1910, Ehrlich 
developed first synthetic antimicrobial drug which 
contains the arsenic compound Salvarsan. Although it 
was not much effective against wide range of 
bacterial infections but it did effective against the 
sleeping sickness (Trypanosomiasis), Spirochaete 
disease of syphilis and Protozoal disease.  Until 1945 
this drug was used then by the discovery of Penicillin 
it was replaced by it. In the middle of last century 
when antibiotics was first introduced it was hailed as 
a wonder drug. The first antibiotic Penicillin, a Beta-
lactam antibiotic was discovered by Alexander 
Fleming. Later Ernst Chain and Howard Florey led 
penicillin to next level to treat infections. Selman 
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Waksman find out the ability of other 
microorganisms to produce anti-bacterial substances 
by using screening method and this technique led to 
successful discovery of Streptomycin. After the 
Second World War, the effort was still continued to 
find out other novel antibiotic structures which led to 
the discovery of many peptide antibiotics i.e., 
(Bacitracin 1945, Chloramphenicol 1947), a Beta-
lactam antibiotics (Cephalosporin C 1955), the 
Tetracycline antibiotics (Chlortetracycline 1948), the 
Cyclic peptide antibiotics (Cycloserine 1955), and the 
Macrolide antibiotics (Erythromycin 1952). 
: 
Adopted from Review of antibiotics http://old.lf3.cuni.cz/studium/materialy/infekce/en_atb.pdf  
In the last fifty years among twenty three thousand bioactive metabolites more than seventeen thousand antibiotics 
were discovered from soil microorganisms [12].  
 
Factors affecting Antibiotic production 
 
Adopted from Chandrashekhara. S, 2010 Vinayaka Mission University, Salem [13] 
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Need of New Antibiotics 
Several new approaches were used to fulfill the need 
of antibiotics. Brute force approach assay bacteria to 
produce antimicrobial substances. Combinatorial 
biosynthesis techniques introduce each 
microorganism in niches and introduce metabolic 
pathways in it resulting in antimicrobial compounds. 
DNA sequencing searches certain DNA from entire 
genome to synthesize anti-microbial products. 
Recently 10,000 Actinomycetes produces antibiotic 
products (phosphoric acid products) using screening 
procedure [7]. Actinomycetes were also grown on a 
medium to check the ability of amino acid arginine 
utilization, used as a nitrogen source [14]. 
 
Classification of Antibiotics 
Antibiotics were most important discovery of 
humankind in modern world. Several important 
microorganisms naturally produced antibiotics. 
Antibiotics produced by Bacterial species include 
Bacitacin from B. licheniformis, Gentamycin from 
Micromonospora purpurea, Gramicidin from 
Bacillus brevis, Polymyin B from B. polymyxal. [15]. 
Antibiotics produced by Streptomyces include 
Streptomycin from S. griseous, Oxytetracycline from 
Srimosus, Erythromycin from S. erythraeus, Nyasin 
from S. noursei, Chlortetracycline from S. 
aurefaciens, Cycloheximide from S. griseous, 
Kanamycin from S. knsnsmyceticus, Amphotericin B 
from S. nodus, Chloramphenicol from S. venezuelal, 
Tetracycline from Streptomyces sp [15, 16]. Potent 
antibiotics by fungi were Penicillin from P. notatum, 
Cephalosporin from Cephalosporium sp, Fusidic acid 
from Fusidium coccineeum and Griseofulvin from 
Penicillium griseofulvium [15, 17]. 
 
Soil as a source of Antimicrobial agents 
Soil is a complex and very diverse environment 
providing versatile source of antibiotic producing 
organisms [18, 19]. Soil contains more organisms 
than there are humans in the planet. Billions of the 
microorganisms live in the soil. It is a lively habitat 
comprised of many living organisms (bacteria, fungi, 
algae, and protozoa, micro-arthropods to the more 
complex nematodes and, insects, earthworms and 
small vertebrates. These organisms grow, eat and 
move in the soil. They decompose organic matter and 
mix humus in the soil layers and organisms live in 
the soil differ in moisture, pH, food available and 
pore size. In the soil the density of living organisms 
is exceptionally high whereas microorganisms were 
less in the cultivated than virgin or uncultivated land 
soil. Soil acidity decreases the population of 
microorganisms [20]. Many soil bacteria that can 
suppress or inhibit other microorganisms competing 
under the same niche were able to produce secondary 
metabolites [21]. Secondary metabolites were 
produced by many microorganisms in soil habitat 
such as bacteria, fungi, Actinomycetes, plants and so 
forth. Among the various groups of organisms, the 
Actinomycetes occupy a prominent place that has the 
capacity to produce such metabolites [22]. 
Identification of antibiotic producing soil bacteria is 
ongoing process nowadays. Several microbiological 
techniques were utilized to examine these 
microorganisms. Approximately 85% of important 
antibiotics were produced by genus bacteria whereas 
filamentous organisms produce 75% of medically 
and commercially useful antibiotics [23]. Number of 
important antibiotics were produced from soil fungi 
has several applications in medical for development 
of pharmaceutical products [24]. Microbial 
population plays an important role in pharmaceutical 
and biotechnological industries as it offers many new 
biochemical pathways and countless new genes to 
probe for enzymes, antibiotics, and other useful 
biological compounds. There are number of 
important microorganisms present in the soil that 
were able to produce industrially and medically 
useful compounds. 
 
Contribution of Microorganisms as a source of 
Secondary metabolites 
History of the microbial technology shows that many 
commercial materials like antibiotics, pesticides 
foods and beverages were produced using many 
microorganisms. During last three decades, for the 
production of new antibiotics with the emergence of 
new diseases screening of microorganisms has 
rapidly increased. The focus of studies was on the 
exploitation of useful antibiotics from Actinomycetes 
& fungi. Studies on the secondary metabolites 
revealed that the secondary metabolites produced 
from different microorganisms have unique 
molecular skeleton [25]. The filamentous 
microorganisms such as fungi and Actinomycetes, 
freshly isolated from soil habitat were the main 
source of secondary metabolites. More than 180 
different secondary metabolites were produced by 
Streptomyces species [26]. 
The groups of bacterial species have the ability to 
produce secondary metabolites. The most common 
species includes the genus of Bacillus which 
produces number of secondary metabolites. Many 
important antibiotics such Bacillaenes, 
Moenomycins, Bacillomycins and Difficidins were 
isolated from different strains of the Bacillus sp [27].  
The most important sources of antibiotics having 
microbial origin are the following groups of 
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microorganisms i.e., Bacteria, Fungi and 
Actinomycetes. 
 
Bacteria: 
Bacteria are single celled, tiny microorganisms and 
somewhat longer in length. They were present in 
numbers. A teaspoon of soil contains 100 million to 1 
billion bacterial species which were active in each 
acre of the soil. Bacteria were easy to isolate and 
culture. They are naturally antibiotic producer in the 
soil for their survival and availability of nutrients. 
Broad spectrum antibiotics were secreted by gram 
negative bacteria. Identification of antibiotic 
producing soil bacteria is ongoing process nowadays. 
Several microbiological techniques were utilized to 
examine these microorganisms. The main antibiotic 
producer includes Bacillus sp and Pseudomonas sp.  
Members of these genera produce several important 
useful antibiotics which includes Polymyxin B, 
Colistin, Gramicidin, Bacitracin and Tyrothricin from 
Bacillus species whereas Pseudomonas species 
produces Pyrrolnitrin and Pyocyanin [28]. Bacillus 
antibiotic production accounts for 70% whereas 13% 
for Pseudomonas [29]. Apart from these two, another 
important genus includes Myxobacterium. 
Approximately 80% of the isolated Myxobacteria 
produce secondary metabolites with antibiotic 
activity, and has the ability to exhibit antifungal 
activity.  
 
Fungi: 
Fungi are the naturally antibiotics producer. 
Penicillin is one of the most important antibiotics 
produced by fungi. Members of Aspergillus, 
Cephalosporium also have the ability to produce 
secondary metabolites. Among these about ten have 
been commercialized i.e., Cephalosporin, Penicillin 
G, V, 0, Griseofulvin, Variotin, Fumagillin, Fusidic 
acid, Xanthocillin and Siccanin [28]. The most 
commonly used fungal antibiotics include Fusidic 
acid, Penicillins and Cephalosporin C which was 
found among the metabolites of different fungal 
species [28]. 
The discovery of new drugs was increasing to 
identify structurally novel compound that possesses 
useful biological activity. Fungus species such as 
Tolypocladium inflatum , T. geodes  and some strains 
of Verticillum sp, Acremonium sp, Beauvaria sp, 
Fusarium sp and Paecilomyces sp [30, 31] were able 
to produce Multipliolides-A, Cyclosporine-A 
whereas some important lactose compounds were 
produced by genus Xylaria mutiplex  [32]. 
Aspergillus sp produce most of the Polyene 
antibiotics. β-lactam antibiotics such as 
Cephalosporin, Pencillin and their relatives were 
produced from Cephalosporium and Penicillium 
group [33] and were used in current chemotherapy 
[34]. Acromonium fusidioides produces Fucidin and 
Fusidic acid having anti bacterial activity against 
gram negative bacteria [35]. Napthaquinones were 
produced by Fusarium solani and Fusarium 
oxysporum with antibacterial properties [36]. 
Cryptosporiopsis guercina have the ability to 
produce Crytocandin. A Lipopeptide antibiotic shows 
strong inhibitory activity against fungi, pathogenic to 
humans i.e., Trichophyton mentagrophytes, 
Trichophyton rubrum, Candida albicans, and against 
plants pathogenic fungi i.e., Botrytis cinerea and S.  
sclerotium [37]. Chaetomin and Epidithiadiketo-
piperazine was produced by specie Chaetomium 
globosum having strong antifungal activity 
[38].Chaetomin was active against gram positive 
bacteria whereas Chaetomium cochlioides  produces 
Cochliodinol exhibits both anti-bacterial and anti-
fungal activity [39]. A Botrydiplodin antibiotic 
produced by Botryosphaeria rhodina sp was active 
against both Gram positive & negative bacteria. A 
compound, Gliovirin produced by Glioclabium virens 
shows antibiotic activity against Pythium ultimum 
[40].  
 
Actinomycetes: 
Actinomycetes were widely distributed and most 
important group of microorganisms in soil. 
Actinomycetes inhabit the soil [41]. Actinomycetes, a 
large group of bacteria are filamentous, gram-
positive, long, unicellular possess both fungal and 
bacterial properties. They grow as hyphae like fungi. 
Actinomycetes are slow growers, active at high Ph, 
decompose chitin and cellulose. They received 
tremendous attention, both scientifically and 
commercially [42]. Major source of Actinomycetes 
was soil [43, 44, 45 and 46] and were the main 
antibacterial producer. The most important 
Actinomycetes genera include Streptomyces, 
Streptosporangium, Microbispora, 
Micromonosporaactinoplanes, Thermoactinomyces, 
Dermatophilus, Nocardia (Farcinica asteroides), 
Nocardia (madurae), Actinomyces (bovis), 
Actinomyces (israeli). The most important soil based 
Actinomycetes were the main source of drugs 
includes Streptomycin, Erythromycin, Actinomycin, 
and Vancomycin. Actinomycin was first of all 
isolated in 1940. 70% of known antibiotics were 
produced by Actinomycetes [47, 48].  
Streptomyces was a genus of Actinomycetes, gram 
positive bacteria, having complex multicellular 
development produce useful antibiotics of natural 
origin i.e., of soil used as pharmaceuticals and 
agrochemicals [49], display anti-bacterial, anti-
fungal, anti-viral, anti-protozoic and antitumor 
properties [23]. Most antibiotics were species 
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specific. Streptomyces species accounts for 90 to 
95% of Actinomycetes sps isolated from soil samples 
[42, 50]. Approximately about 92% of the antibiotics 
of Actinomycetes origin discovered till date have 
been isolated from Streptomyces sp. Actinomycetales 
have the greatest number of antibiotics used 
commercially and about 72 of them being utilized for 
various purposes [28]. 
 
Bioactivity of Secondary metabolites 
Biological activities were exhibited by several 
microorganisms that were able to produce secondary 
metabolites. Microorganisms having incredible array 
of chemical structures were able to produce 
secondary metabolites and results in versatile 
biological activity. An important new feature in the 
exploitation of microorganisms was utilization of 
microbial metabolites in pharmacological fields 
(Statins, Cyclosporin) [51]. Secondary metabolites 
produced by several microorganisms were utilized 
directly in medicine, pharmaceuticals and agriculture 
and also in the biological and chemical derivitization 
to design rational drugs.  
 
Biodiversity of Microorganisms 
Biodiversity refers to the taxonomical entities or 
number of species in a given geographic area or 
ecosystem and were studied specifically for their 
value as organic compounds producers which is so 
called secondary metabolites. These compounds were 
studied, isolated and characterized by biologists & 
chemists for the evaluation of their pharmacological, 
biological and chemotaxonomic potential in order to 
explore the chemical diversity. Till date 
approximately six thousand species of the 
prokaryotes especially bacteria were known. It is 
estimated that about 106 to 109 bacterial strains exist 
in the nature and about seven thousand fungal species 
were known and they were expected to increase in 
the future [52]. The above calculation of 
microorganisms provides an estimated data for the 
researchers to exploit secondary metabolites. 
Filamentous species i.e. fungi and Actinomycetes 
were tremendous source of secondary metabolites 
representing 60% of the total bioactive microbial 
secondary metabolites [12]. Certain genera of fungi 
such as Trichoderma, Penicillium, Fusarium & 
Aspergillus sps were the tremendous producers of the 
secondary metabolites [53]. Every day new species of 
fungi and Actinomycetes are being discovered which 
opens tremendous opportunities for the scientists and 
it also evidences that our knowledge of these 
microorganisms is far from exhaustive. 
 
FUTURE PERSPECTIVE OF SECONDARY 
METABOLITES: 
In 21st Century improvement in technologies 
advances the production & synthesis of natural 
products. Natural products and related structures 
become even more important and it focuses the study 
around itself for the development of improved new 
medicines due to its important discoveries of 
functionally relevant microbial origin secondary 
metabolites. In the treatment of resistant pathogens 
currently available antibiotics might remain useful 
but it is possible that in the future physicians will run 
out of options. New approaches are required to 
combat the spread of drug resistant bacterial 
pathogens and the emerging infections globally. One 
of the most important issues is the pattern or increase 
in the death rates from infectious diseases. In the 20th 
century from 1900-1980 the rate dropped from 797 
per 100,000 people to 36 per 100,000 people. A 
reduction is made by a factor of more than 20 and a 
testament in part to the efficacy of the antibiotics 
[55].   
In spite of availability of many antibiotics, the need 
for the discovery and development of new ones still 
exists in order to solve the therapeutic problems in 
future, which includes the continuing problem of 
drug resistance amongst the pathogenic species. 
Organisms which were previously seem to be 
commensals are now becoming the dangerous 
pathogens due to the abuse of the antibiotics. 
Example includes the species of Staphylococcus, 
Proteus and Yeasts. Currently few satisfactory 
systemic antifungal antibiotics exist outside the 
Amphotericin-B but unfortunately even 
Amphotericin-B is not always effective. The need for 
new antibiotics is growing to be used in the 
agriculture for combating plant diseases and antiviral 
agents must also need to be developed [54]. 
These were the some of the major problems that 
cannot be solved by chemical synthesis of the 
antibiotics alone so need for new antibiotics 
exhibiting new profiles of mechanism and activity 
may be found mainly by further systematic 
screenings of soil microorganisms and this needs to 
be performed according to the new fundamental 
principles. 
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